UK health officials are under pressure to investigate deaths linked to black market weight loss injections, as restricted access to NHS obesity drugs drives individuals to seek unregulated alternatives. During a session with the Health and Social Committee, Conservative MP Gregory Stafford warned that current NHS constraints pose a patient safety risk. Public health minister Sharon Hodgson acknowledged this issue, stating that limited access could push patients towards unsafe sources. Professor Aidan Fowler, national director of patient safety for NHS England, noted that discussions with the Medicines and Healthcare products Regulatory Agency (MHRA) often focus on the risks associated with black market medicines. Committee chairwoman Layla Moran recounted harrowing stories of families who lost loved ones due to complications from black market injections. In response, Hodgson stressed the importance of accelerating the rollout of obesity drugs, admitting that current treatment numbers are insufficient. She also proposed a new single patient record system to better identify those eligible for treatment.